Fine lacquerware puts new sheen on Gaya craftsmanship
Dish on cone-shaped stand shows high level of artistic sophistication, researchers say
CHANGWON, South Gyeongsang Province — A decade since an archaeological excavation, government researchers are now shedding light on ancient craft-making in the southern part of Korean Peninsula.
'This dish on high pedestal demonstrates the sophistication of Korean craft some 2,000 years ago,' Kim Ji-yeon, a researcher at the Gaya National Research Institute of Cultural Heritage, told reporters as she held a dish on a pointed stand Monday.
Kim is a member of a Korea Heritage Service-run team that studies discoveries related to Gaya (42-562), a confederacy of city-states that was later annexed by the Silla Kingdom (57 BC–935 AD). The team, launched in 2015, believes its findings could reshape our understanding of the ancient confederacy, from everyday life to life in the palace.
The lacquered Gaya dish on a pointed stand, Kim said, shows exceptional craftsmanship: The stem connecting the dish and the base is the thinnest in East Asia, and the mounted dish, stem and base were crafted out of a single wooden piece, a technologically more challenging feat compared to creating the parts separately and joining them later.
The dish on a pointed stand was one of the 15 artifacts whose discovery was announced Monday, lacquered wooden dishwares excavated at the end of last year at a site in Bonghwa-dong in Gimhae, South Gyeongsang Province.
Digging at the site, the Gaya palace grounds, began in 2015. The artifacts were moved to nearby Changwon where the Gaya National Research Institute showcased them in tightly-sealed glass boxes.
The artifacts are thought to have been used for ancestral rites and likely made between the first and fourth centuries, according to Kim.
'It's also quite unusual to see all these 15 pieces in good condition overall,' Kim said of the pieces, made of East Asian alder wood, which is resistant to the effects of bad weather.
In addition to the 15 artifacts, the institute excavated some 300 items of wooden lacquerware including dishware, household items and farming tools. They, too, were made between the first and fourth centuries, according to the institute.
The Gimhae excavation project is expected to run through 2027 as researchers identify the artifacts.
Meanwhile, the Korea Heritage Service opened a storage facility inside an abandoned tunnel in Haman-gun in South Gyeongsang Province to store relics found nearby.
The Mogok Tunnel storage marks the fourth of its kind since 2021, and the agency said it will build a nationwide network of storage facilities as demand for them grows.
Lee Jong-hoon, the KHS director general, likened storage facilities to 'cultural stations,' saying residents nearby can drop by to see not only artifacts but interactive exhibitions related to them, as well.
siyoungchoi@heraldcorp.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
3 days ago
- Korea Herald
Daewoong partners with Sweden's Salipro to boost drug discovery
Daewoong Pharmaceutical on Wednesday announced a strategic research partnership with Swedish biotech company Salipro Biotech to jointly develop next-generation therapeutics targeting membrane proteins. Under the agreement, Salipro will provide Daewoong access to its proprietary Salipro Platform, a technology that stabilizes membrane proteins in a near-native environment, making them more accessible for drug discovery. Membrane proteins are involved in essential cellular functions and account for over 60 percent of known drug targets, yet their structural instability in lab conditions has long been a barrier to research. The partnership is Salipro's first with a Korean company and follows previous collaborations with major pharmaceutical firms including Boehringer Ingelheim, Sanofi and Sumitomo. Daewoong views the alliance as a key step in its open innovation strategy, aiming to bolster its global competitiveness and lay the groundwork for potential overseas licensing deals. 'Our partnership with Daewoong marks Salipro's first collaboration with a Korean company, making it especially meaningful,' Jens Frauenfeld, CEO of Salipro Biotech, stated. 'The Salipro platform enables research on previously inaccessible target proteins and is expected to unlock new possibilities in global innovative drug development.' Park Seong-soo, CEO of Daewoong Pharmaceutical, added, 'We expect that the Salipro platform will enhance our access to challenging membrane protein targets and accelerate our drug discovery efforts. Through an open collaboration strategy, we will continue to develop globally competitive new drugs.'
Korea Herald
4 days ago
- Korea Herald
Alamar Biosciences, Alzheimer's Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer's Disease.
Multi-center project will profile over 40,000 samples using ultra-sensitive NULISA™ technology. FREMONT, Calif., June 10, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, the Alzheimer's Disease Data Initiative and Gates Ventures today announced a strategic partnership with the goal to generate one of the largest proteomic datasets linked to clinical outcomes in Alzheimer's Disease (AD). This international project will profile over 40,000 plasma samples representing AD and related dementias using Alamar's ultra-sensitive NULISA™ technology, with the goal of accelerating biomarker discovery and driving new insights into the progression and treatment of AD. "This collaboration reflects our shared commitment to transform the landscape of Alzheimer's research through data, technology, and global partnerships," said Yuling Luo, PhD, Founder, Chairman and CEO of Alamar Biosciences. "By combining our NULISA platform with Alzheimer's Disease Data Initiative's infrastructure and Gates Venture's mission-driven investment, we aim to catalyze a new era of biomarker-driven discovery and therapeutic development." As part of the initiative, Alamar's NULISAseq™ CNS Disease Panel 120 and Inflammation Panel 250 will be implemented at research centers in the United States, Sweden, United Kingdom, and India. These panels deliver unparalleled sensitivity and specificity, enabling the accurate measurement of hundreds of brain- and immune-related proteins from just a small volume of blood or cerebrospinal fluid. A key feature of the CNS panel is its unique ability to distinguish brain-derived phosphorylated tau from total phosphorylated tau in blood—a critical advancement for the development of community-based screening programs. The resulting proteomic data will be integrated with clinical and longitudinal outcome measures and shared with the global research community by leveraging the Global Neurodegeneration Proteomics Consortium 's (GNPC) secure data-sharing processes. "Understanding the biological underpinnings of Alzheimer's Disease is essential for developing effective treatments," said Niranjan Bose, Managing Director of Health & Life Sciences at Gates Ventures and interim Executive Director of the Alzheimer's Disease Data Initiative. "This initiative will provide a rich resource to researchers worldwide and help overcome long-standing barriers in early detection and stratified interventions." This initiative represents a major step forward in building a comprehensive, clinically annotated Alzheimer's plasma proteome atlas, with the potential to unlock new biomarkers for diagnosis, prognosis, and therapeutic response. This strategic collaboration complements the efforts of the GNPC, which has brought together top dementia researchers and datasets to collaborate and create one of the largest disease-specific proteomics datasets ever assembled. The project also emphasizes inclusivity by incorporating diverse cohorts from multiple geographic and ethnic populations. About the Alzheimer's Disease Data Initiative The Alzheimer's Disease Data Initiative is a coalition of leading academic, advocacy, government, industry, and philanthropy organizations that recognizes the need for dementia researchers to find easier ways to share data, analytical tools, and scientific findings. These partners are working together to accelerate progress towards new diagnostics, treatments, and cures for Alzheimer's disease and related dementias. Learn more about the Alzheimer's Disease Data Initiative at About Alamar Biosciences, Inc. Alamar Biosciences is a privately held life sciences company with a mission to power precision proteomics to enable the earliest detection of disease. The company's proprietary NULISA Platform along with the ARGO™ HT System work seamlessly with the latest advances in genomics to achieve single digit attomolar detection sensitivity, greatly surpassing the most sensitive protein detection technology on the market today. For more information, please visit
Korea Herald
4 days ago
- Korea Herald
AI teaching assistant shows real promise at S. Korea tech university KAIST
South Korea's top science and engineering university has rolled out a custom-built AI teaching assistant to help students in large graduate courses, and early results show it helped reduce repetitive student questions while encouraging more active, self-directed learning. At Korea Advanced Institute of Science and Technology, a team of researchers led by AI graduate school professor Choi Yoon-jae and design professor Hong Hwa-jung developed a virtual teaching assistant, or VTA, that can answer student questions at any time, with responses tailored to specific lectures and coursework. The tool was piloted last fall in a programming class for AI, taken by 477 graduate students. It's the first time such a system has been tested at scale in a Korean university setting. What sets the KAIST VTA apart is that it isn't a generic chatbot. Instead, it runs on what's called a retrieval-augmented generation model, which pulls directly from course materials like slides, coding exercises and lecture videos. When students ask a question, the system finds the most relevant content and formulates a response based on that context. This means answers are grounded in what's actually taught, not just generated from a general AI model. Over 50 percent of students used the system regularly during the 14-week semester, generating nearly 3,870 questions and answers. Students without a strong background in AI or coding were among the most active users, suggesting the VTA helped close knowledge gaps for those new to the subject. These figures come from internal usage data collected by KAIST during the semester. The system didn't just benefit students. According to lead TA and doctoral researcher Kwon Soon-jun, it reduced the number of routine questions from students, such as basic concept definitions or explanations already given in class. That allowed human teaching assistants to focus more on deeper, more complex issues. Compared to the previous year's course, the volume of questions requiring direct responses from TAs dropped by around 40 percent, based on data compiled by Professor Choi. Students also appeared more comfortable asking questions through the VTA than to human TAs, especially when it came to theoretical topics. Surveys conducted by Choi's research team before, during and after the course showed that students became increasingly confident in the system's reliability, and those who had been hesitant to speak up in class reported higher satisfaction levels when using the AI assistant. The VTA's source code has been released publicly on GitHub to encourage adoption by other educators and researchers. The work was also accepted to the Industry Track at ACL 2025, one of the leading international conferences in natural language processing
